NSC |
Compound |
Enrichment |
Correlation |
NSC 682996 |
Null |
0.0212053315848711 |
-0.040364936 |
NSC 709358 |
1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol |
0.0212053315848711 |
-0.28724 |
NSC 711077 |
Null |
0.0212053315848711 |
0.064837631 |
NSC 716503 |
Null |
0.0212053315848711 |
-0.0078689744 |
NSC 731704 |
1-[4-Ethoxycarbonyl)homopiperazine-1-yl]diazen-1-ium-1,2-dio late. |
0.0212053315848711 |
0.13510524 |
NSC 743433 |
8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one |
0.0212053315848711 |
0.063241019 |
NSC 755442 |
Null |
0.0212053315848711 |
0.045136643 |
NSC 762901 |
trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide |
0.0212053315848711 |
0.036834587 |
NSC 683557 |
Camptothecin Derivative |
0.0220292715546631 |
-0.13825942 |
NSC 697685 |
Null |
0.0220292715546631 |
0.0036136499 |